Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FUJRP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,678.70 by the Defense Logistics Agency (DLA) on August 20, 2025. The contract covers the supply of Nucala 100 mg/ml auto-injector medication, with an ultimate completion date of August 21, 2025. This delivery order was issued under a firm fixed-price arrangement with no set-aside designation, allowing the vendor to compete on an open basis despite its small business status.
This award represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499.999 billion and remains valid through November 2026. The IDC establishes DMS Pharmaceutical Group as a primary supplier for pharmaceutical products supporting military healthcare facilities nationwide, encompassing prescription medications, biologics, over-the-counter items, and specialty pharmaceuticals. The DLA utilizes this contract vehicle to efficiently procure medical supplies for Department of Defense healthcare sites across the globe, with individual delivery orders such as this one fulfilling specific inventory and patient care requirements.
Quick answers
Who was awarded contract SPE2DB25FUJRP?
SPE2DB25FUJRP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FUJRP worth?
The government has obligated $5,679 on SPE2DB25FUJRP.
Is contract SPE2DB25FUJRP an order under another contract?
Yes. SPE2DB25FUJRP is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJRP competed?
The extent of competition for SPE2DB25FUJRP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award